Kaplan–Meier survival curves demonstrated a significant decrease in OS among GC patients with high GPX4 expression, suggesting that GPX4 may be a crucial prognostic factor for GC patients (Fig. 9). This evidence concerns the gene GPX4 and gastric cancer.